Pathogenic role of advanced glycosylation end products in diabetic nephropathy

Kidney International, Supplement

Volumn 51, Issue 60, 1997, Pages

  Hi Bahl Lee, ^a   Mi Kyoung Cha, ^a   Kyoung Il Song, ^a   Jeong Ho Kim, ^a   Eun Young Lee, ^a   Sung Il Kim, ^a   Kim, J ^a   Myung Hi Yoo, ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

Advanced glycosylation end products; Diabetic nephropathy; Laminin; Transforming growth factor 1; Type IV collagen

Indexed keywords

AMINOGUANIDINE; COLLAGEN TYPE 4; INSULIN; LAMININ B1; MESSENGER RNA; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ADVANCED GLYCATION END PRODUCT;

ANIMAL CELL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

DIABETIC NEPHROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS;

EID: 45849155144     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)